USP15 and urinary bladder carcinoma: BRCA1 is a crucial component of the BRCC3 complex, leading to our conjecture that USP15 may activate the NF-κB pathway by deubiquitinating BRCC3, thereby augmenting its expression and ultimately influencing bladder cancer progression.